J&J’s cardiovascular unit stands out again in Q1
MedTech Dive • April 14, 2026
|
Medline recalls angiographic syringes, receives FDA warning letter
MedTech Dive • April 14, 2026
|
Latest News on MassDevice - MassDevice
MassDevice • April 15, 2026
|
Stereotaxis to acquire Robocath for up to $45M - MassDevice
MassDevice • April 15, 2026
|
Latest News on MassDevice - MassDevice
MassDevice • April 15, 2026
|
Heartflow sues Cleerly over alleged patent infringement - MassDevice
MassDevice • April 15, 2026
|
Edwards announces new heart valve health initiative with David Letterman's IndyCar racing team - MassDevice
MassDevice • April 14, 2026
|
MMI debuts microsurgical suture for robotic surgery in the U.S. - MassDevice
MassDevice • April 14, 2026
|
Johnson & Johnson ups 2026 outlook on Q1 beats, MedTech sales rise 7.7% - MassDevice
MassDevice • April 14, 2026
|
Calyxo raises $40M for kidney stone removal system - MassDevice
MassDevice • April 14, 2026
|
Reach Surgical wins CE mark for reusable stapler - MassDevice
MassDevice • April 15, 2026
|
AliveCor wins CE mark for 12-lead ECG - MassDevice
MassDevice • April 15, 2026
|
How Insulet taps into pop culture to spread the word on Omnipod through ‘Scrubs,’ Marvel - MassDevice
MassDevice • April 15, 2026
|
Wavelet Medical picks up funding to advance AI-powered fetal EEG - MassDevice
MassDevice • April 14, 2026
|
Abbott data highlights reduced complications with Aveir AR leadless atrial pacemaker - MassDevice
MassDevice • April 14, 2026
|
Labcorp launches rapid fentanyl test with 48-hour detection window
Fierce Biotech • April 15, 2026
|
Terremoto takes $108M series C to fuel clinical trials of AKT1 inhibitors
Fierce Biotech • April 15, 2026
|
Bain-backed Beeline Medicines buzzes out of stealth with $300M and 5 programs from BMS
Fierce Biotech • April 14, 2026
|
FDA official confirms plausible mechanism principles not exclusive to bespoke gene therapies
Fierce Biotech • April 14, 2026
|
Cell therapy biotech Obsidian leverages Galera reverse merger to go public
Fierce Biotech • April 14, 2026
|
Astellas to close stem cell unit’s Seattle site, with layoffs incoming
Fierce Biotech • April 14, 2026
|
Click Therapeutics cuts staff after commercial deal restructuring
Fierce Biotech • April 14, 2026
|
Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
Fierce Biotech • April 14, 2026
|
Australia’s Kazia pays research institute $1.4M for epigenetic platform, preclinical drug
Fierce Biotech • April 14, 2026
|
Takeda terminates mRNA research pact with Japanese drug discovery specialist
Fierce Biotech • April 14, 2026
|
Stryker makes a buy as Avanos Medical to go private in a spate of medtech M&A deals
Fierce Biotech • April 14, 2026
|